What are the responsibilities and job description for the EXECUTIVE DIRECTOR, GLOBAL MARKET ACCESS STRATEGY position at Sarepta Therapeutics, Inc.?
Why Sarepta? Why Now?
The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development in gene therapy, RNA and gene editing. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne.
We're looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients.
What Sarepta Offers
At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and work-life resources designed to support people in the following areas :
- Physical and Emotional Wellness
- Financial Wellness
- Support for Caregivers
For a full list of our comprehensive benefits, see our website : https : / / www.sarepta.com / join-us
The Importance of the Role
Reporting to the Head of Global Market Access Strategy (GMAX), the Executive Director, GMAX drives market access strategy for key Sarepta assets, including ELEVIDYS (delandistrogene moxepavovec, SRP-9001) with influential leadership that represent the goals and priorities of the broader International Business Unit to cross functional teams such as the Global Product Team (GPT) or Customer Org Sub-Team (CT).
In collaboration with the broader International Business Unit, the GMAX team proactively monitors external market access / evidence generation requirements and drives development of market access strategies, including development of the global payer value proposition and evidence generation strategies for Sarepta's assets in development as well as marketed therapies, to optimize access.
The Opportunity to Make a Difference
Pressure testing value assumptions and evidence requirements (testing TPP, key value drivers)
More about You
What Now?
We're always looking for solution-oriented, critical thinkers.
So, if you're comfortable with ambiguity and candor, relish challenging yourself, and place kindness and integrity at the forefront of how you approach your peers and work, then we encourage you to apply.
LI-Hybrid
LI-TR1
This position is hybrid, you will be expected to work on site at one of Sarepta's facilities in the United States and / or attend Company-sponsored in-person events from time to time.
The targeted salary range for this position is $248,000 - $310,000 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta's compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity.
Candidates must be authorized to work in the U.S.
Sarepta Therapeutics offers a competitive compensation and benefit package.
Sarepta Therapeutics is an Equal Opportunity / Affirmative Action employer and participates in e-Verify.
Salary : $248,000 - $310,000